Sort
15,842 grants matching “pancreatic cancer”
New Strategy for Pancreatic Cancer Therapy
$165,210Joyce C Solheim · University Of Nebraska Medical Center · R21 · FY2018 · CA
H3K9 Methylation and Pancreatic Cancer Chemoresistance
$165,209Kebin Liu · Augusta University · R21 · FY2015 · CA
Neoglycosylation Epitopes in Metaplasia and Cancer
$165,062Jeffrey Wade Brown · Washington University · K08 · FY2025 · DK
Neoglycosylation Epitopes in Metaplasia and Cancer
$165,062Jeffrey Wade Brown · Washington University · K08 · FY2024 · DK
Neoglycosylation Epitopes in Metaplasia and Cancer
$165,062Jeffrey Wade Brown · Washington University · K08 · FY2023 · DK
Proteome of Pancreatic Zymogen Granules
$165,029Michael J. Rindler · New York University School Of Medicine · R21 · FY2006 · DK
Novel Suppressors of Pancreatic Cancer
$165,000Dawn E Quelle · University Of Iowa · R21 · FY2010 · CA
Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer
$165,000Joseph J Cullen · University Of Iowa · R21 · FY2009 · CA
Enhancement of Cancer Therapy Using Ketogenic Diets
$165,000Douglas Robert Spitz · University Of Iowa · R21 · FY2010 · CA
Cetuximab Therapy of Pancreatic Cancer: Immune Modulation with IL-21
$165,000William E. Carson · Ohio State University · R21 · FY2010 · CA
Tissue Modeling Core
$164,986Hernan Alcides Flores-Rozas · Florida Agricultural And Mechanical Univ · U54 · FY2018 · CA
Animal Tumor Models
$164,789Ruby Yanru Chen-Tsai · Stanford University · P30 · FY2014 · CA
Somatostatin receptor 2 (SSTR2) antibody-drug conjugate for pancreatic neuroendocrine tumor (PanNET) therapy
$164,785Renata Jaskula-Sztul · University Of Alabama At Birmingham · R21 · FY2021 · CA
Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma
$164,756Tad H Koch · University Of Colorado · R21 · FY2012 · CA
Loss of the Exocrine Pancreas Improves Glucose Tolerance and Insulin Secretion
$164,688Mohamed Saleh · University Of Pittsburgh At Pittsburgh · K08 · FY2022 · DK
A promising small molecule for pancreatic cancer therapy
$164,641Arun K Sharma · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2020 · CA
Pharmacogenomics of a Cytidine Analogue, Gemcitabine
$164,486Liewei Wang · Mayo Clinic Rochester · K22 · FY2010 · CA
Pharmacogenomics of a Cytidine Analogue, Gemcitabine
$164,484Liewei Wang · Mayo Clinic Rochester · K22 · FY2009 · CA
Targeting ATDC with PARP inhibitors in pancreatic cancer
$164,463Mats Ljungman · University Of Michigan At Ann Arbor · R21 · FY2010 · CA
Core 3: Family and Population Registries Core
$164,430Francis M Giardiello · Johns Hopkins University · P50 · FY2021 · CA
Preclinical Modelling and Therapeutic Development for Other Cancer Indications
$164,392Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure
$164,392Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2021 · CA
RNases for understanding the origin of new gene function
$164,345Jianzhi Zhang · University Of Michigan At Ann Arbor · R01 · FY2006 · GM
The role of Hedgehog in hematopoiesis and leukemogenesis
$164,250Inga Hofmann Zhang · Boston Children'S Hospital · K08 · FY2012 · CA
Evaluation of MSP Antagonists for the Treatment of Pancreatic Cancer
$164,213Joseph W Harding · Washington State University · R21 · FY2013 · CA